Missed NVDA?
Don’t Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities — for free.
LGST Stock Forecast 2026-2027
$5.81
Current Price
$86.78M
Market Cap
Buy 0
Hold 0
Sell 0
Wall St Analyst Ratings
Distance to LGST Price Targets
N/A
To High Target of $N/A
N/A
To Median Target of $N/A
N/A
To Low Target of $N/A
LGST Price Momentum
+30.3%
1 Week Change
-25.4%
1 Month Change
+481.0%
1 Year Change
+1,660.6%
Year-to-Date Change
-62.2%
From 52W High of $15.38
+2,425.0%
From 52W Low of $0.23
📊 TOP ANALYST CALLS
Did LGST Make This Month's Elite Buy List?
We don't follow just any analyst — only the top 3% with a proven track record make our cut. See if Semper Paratus is one of their latest high-conviction picks.
Latest LGST Stock Price Targets & Analyst Predictions
LGST has shown a year-to-date change of 1,660.6% and a 1-year change of 481.0%, reflecting upward momentum over the past year. Comprehensive analyst forecasts are currently unavailable for LGST. Please refer to the price chart above for recent performance and trends.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
LGST Analyst Ratings
0
Buy
0
Hold
0
Sell
LGST Price Target Range
Low
N/A
Average
N/A
High
N/A
Current: $5.81
Latest LGST Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for LGST.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|
Semper Paratus Acquisition Corporation (LGST) Competitors
The following stocks are similar to Semper Paratus based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Semper Paratus Acquisition Corporation (LGST) Financial Data
Valuation Metrics
Market Cap
$86.78M
Enterprise Value
$0
P/E Ratio
50.1x
PEG Ratio
N/A
Price/Sales
N/A
Growth & Margins
Revenue Growth (YoY)
N/A
Gross Margin
N/A
Operating Margin
N/A
Net Margin
N/A
EPS Growth
N/A
Financial Health
Cash/Price Ratio
+0.4%
Current Ratio
0.2x
Debt/Equity
0.0x
ROE
+1.3%
ROA
+1.2%
💡 SKIP THE NOISE
97% of Analyst Ratings Go Nowhere
We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings — tracked and updated every Monday and Thursday.
Semper Paratus Acquisition Corporation (LGST) Business Model
About Semper Paratus Acquisition Corporation
What They Do
Specializes in mergers and acquisitions.
Business Model
The company operates as a blank check company, planning to engage in business combinations with firms primarily within the transportation, supply chain, and logistics sectors. It raises capital through an initial public offering (IPO) and uses those funds to acquire or merge with target companies.
Additional Information
Incorporated in 2021 and based in New York, Semper Paratus Acquisition Corporation is a subsidiary of Ssvk Associates, LLC, which may provide additional support and resources for its acquisition strategy.
Company Information
Sector
Financial Services
Industry
Shell Companies
Employees
0
CEO
Mr. Surendra K. Ajjarapu
Country
United States
IPO Year
2022
Website
www.semperparatusspac.comSemper Paratus Acquisition Corporation (LGST) Latest News & Analysis
Latest News
Quick Summary
Tevogen Bio Holdings Inc. has completed its business combination with Semper Paratus Acquisition Corp. The new company's stock (TVGN) and warrants (TVGNW) will trade on Nasdaq starting February 15, 2024.
Why It Matters
Tevogen Bio's merger and Nasdaq listing signal a new investment opportunity in the biotech sector, potentially attracting interest due to its focus on innovative T cell therapies.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Semper Paratus Acquisition Corporation's Shareholders Approve Business Combination with Tevogen Bio
2 years ago
Quick Summary
Semper Paratus Acquisition Corporation's shareholders approved the business combination with Tevogen Bio Inc. during a meeting on January 31, 2024.
Why It Matters
The approval of Semper Paratus's merger with Tevogen Bio could lead to increased stock volatility and potential growth opportunities, impacting investor sentiment and market positioning.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Semper Paratus Acquisition Corporation Announces Anticipated Listing of Tevogen Bio Holdings Inc. on Nasdaq
2 years ago
Quick Summary
Semper Paratus Acquisition Corp. filed a Prospectus Supplement for its Jan. 29, 2024, shareholder meeting to vote on a merger with Tevogen Bio, leading to a name change to Tevogen Bio Holdings Inc.
Why It Matters
The proposed merger could significantly impact the valuation and future growth potential of Semper Paratus, potentially reshaping investor sentiment and stock performance.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Quick Summary
Tevogen Bio and Semper Paratus Acquisition Corporation announced that the SEC has declared effective their registration statement for a proposed business combination.
Why It Matters
The SEC's approval of the registration statement signals progress in the Tevogen Bio and Semper Paratus merger, potentially enhancing investor confidence and impacting stock performance.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Semper Paratus Acquisition Corporation Regains Compliance with Certain Nasdaq Listing Requirement
2 years ago
Quick Summary
Semper Paratus Acquisition Corporation (Nasdaq: LGST) has regained compliance with Nasdaq's MVLS rule, confirming a market value of listed securities over $50 million for continued listing.
Why It Matters
Regaining compliance with Nasdaq's listing requirements enhances Semper Paratus Acquisition Corporation's credibility and stability, potentially attracting more investors and boosting stock performance.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Quick Summary
Semper Paratus Acquisition Corp (Nasdaq: LGST) filed a Form S-4 registration statement with the SEC for its proposed business combination with Tevogen Bio Inc, a biotech firm specializing in T cell therapeutics.
Why It Matters
The filing of the registration statement indicates progress in the merger, which could enhance Semper Paratus' value and attract investor interest in Tevogen Bio's innovative therapies.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Frequently Asked Questions About LGST Stock
What is Semper Paratus Acquisition Corporation's (LGST) stock forecast for 2026?
Analyst forecasts for Semper Paratus Acquisition Corporation (LGST) are not currently available. The stock is trading at $5.81.
Is LGST stock a good investment in 2026?
Analyst ratings for LGST are not currently available. The stock is currently trading at $5.81. Investment decisions should be based on thorough research and your personal financial goals. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for LGST stock?
Price predictions from Wall Street analysts for LGST are not currently available. The stock is trading at $5.81.
What is Semper Paratus Acquisition Corporation's business model?
The company operates as a blank check company, planning to engage in business combinations with firms primarily within the transportation, supply chain, and logistics sectors. It raises capital through an initial public offering (IPO) and uses those funds to acquire or merge with target companies.
What is the highest forecasted price for LGST Semper Paratus Acquisition Corporation?
Price targets from Wall Street analysts for LGST are not currently available. The stock is trading at $5.81.
What is the lowest forecasted price for LGST Semper Paratus Acquisition Corporation?
Price targets from Wall Street analysts for LGST are not currently available. The stock is trading at $5.81.
What is the overall LGST consensus from analysts for Semper Paratus Acquisition Corporation?
Analyst ratings for LGST are not currently available. The stock is trading at $5.81.
How accurate are LGST stock price projections?
Stock price projections, including those for Semper Paratus Acquisition Corporation, are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Last updated: April 10, 2026 10:22 AM UTC